| Sandhills Behavioral Services Llc | |
|
356 S Main St Ste C Ainsworth NE 69210-2032 | |
| (402) 382-3555 | |
| Not Available |
| Full Name | Sandhills Behavioral Services Llc |
|---|---|
| Speciality | Counselor |
| Location | 356 S Main St Ste C, Ainsworth, Nebraska |
| Authorized Official Name and Position | Murlene Osburn (NP/OWNER) |
| Authorized Official Contact | 4023823555 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Sandhills Behavioral Services Llc 356 S Main St Ste C Ainsworth NE 69210-2032 Ph: () - | Sandhills Behavioral Services Llc 356 S Main St Ste C Ainsworth NE 69210-2032 Ph: (402) 382-3555 |
| NPI Number | 1033646799 |
|---|---|
| Provider Enumeration Date | 05/12/2017 |
| Last Update Date | 05/12/2017 |
| Medicare PECOS PAC ID | 0648513119 |
|---|---|
| Medicare Enrollment ID | O20190524000747 |
News Archive
Increasing diabetes awareness and integrating a multi-faceted, approach to improve patient care and education, results in significantly improved patient outcomes, according to a report in the April issue of Clinical Diabetes, a publication of the American Diabetes Association.
Halozyme Therapeutics, Inc. today announced the issuance of U.S. Patent No. 7,767,429 claiming its proprietary recombinant human hyaluronidase enzyme platform (rHuPH20). Claims to the human PH20 glycoprotein, PEGylated variants, the glycoprotein produced by recombinant methods, and pharmaceutical compositions with other agents, including antibodies, insulins, cytokines, anti-infectives and additional therapeutic classes were awarded in the '429 patent. Additional claims are in prosecution.
Sentry BioPharma Services announced today that The Centers for Disease Control & Prevention (CDC) selected Sentry to store and distribute influenza vaccine in support of its national strategic reserve. Sentry will warehouse and distribute vaccine from its cGMP, FDA-registered facility located in Indianapolis, Ind. Sentry's vast experience storing and transporting regulated, temperature-sensitive pharmaceutical products will ensure product integrity, supply chain security and fast, efficient distribution of the disease-preventing vaccines.
Temasek Life Science Ventures Pte Ltd and Emergent BioSolutions Inc. today announced their agreement to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture, and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused by a broad range of circulating H5 influenza strains.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033646799 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Provider Name | Murlene N Osburn |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1457788531 PECOS PAC ID: 8224343520 Enrollment ID: I20150817000225 |
News Archive
Increasing diabetes awareness and integrating a multi-faceted, approach to improve patient care and education, results in significantly improved patient outcomes, according to a report in the April issue of Clinical Diabetes, a publication of the American Diabetes Association.
Halozyme Therapeutics, Inc. today announced the issuance of U.S. Patent No. 7,767,429 claiming its proprietary recombinant human hyaluronidase enzyme platform (rHuPH20). Claims to the human PH20 glycoprotein, PEGylated variants, the glycoprotein produced by recombinant methods, and pharmaceutical compositions with other agents, including antibodies, insulins, cytokines, anti-infectives and additional therapeutic classes were awarded in the '429 patent. Additional claims are in prosecution.
Sentry BioPharma Services announced today that The Centers for Disease Control & Prevention (CDC) selected Sentry to store and distribute influenza vaccine in support of its national strategic reserve. Sentry will warehouse and distribute vaccine from its cGMP, FDA-registered facility located in Indianapolis, Ind. Sentry's vast experience storing and transporting regulated, temperature-sensitive pharmaceutical products will ensure product integrity, supply chain security and fast, efficient distribution of the disease-preventing vaccines.
Temasek Life Science Ventures Pte Ltd and Emergent BioSolutions Inc. today announced their agreement to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture, and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused by a broad range of circulating H5 influenza strains.
› Verified 1 days ago
News Archive
Increasing diabetes awareness and integrating a multi-faceted, approach to improve patient care and education, results in significantly improved patient outcomes, according to a report in the April issue of Clinical Diabetes, a publication of the American Diabetes Association.
Halozyme Therapeutics, Inc. today announced the issuance of U.S. Patent No. 7,767,429 claiming its proprietary recombinant human hyaluronidase enzyme platform (rHuPH20). Claims to the human PH20 glycoprotein, PEGylated variants, the glycoprotein produced by recombinant methods, and pharmaceutical compositions with other agents, including antibodies, insulins, cytokines, anti-infectives and additional therapeutic classes were awarded in the '429 patent. Additional claims are in prosecution.
Sentry BioPharma Services announced today that The Centers for Disease Control & Prevention (CDC) selected Sentry to store and distribute influenza vaccine in support of its national strategic reserve. Sentry will warehouse and distribute vaccine from its cGMP, FDA-registered facility located in Indianapolis, Ind. Sentry's vast experience storing and transporting regulated, temperature-sensitive pharmaceutical products will ensure product integrity, supply chain security and fast, efficient distribution of the disease-preventing vaccines.
Temasek Life Science Ventures Pte Ltd and Emergent BioSolutions Inc. today announced their agreement to form EPIC BIO Pte Ltd, a joint venture to develop, manufacture, and commercialize a multivalent, cross-protective human vaccine to protect against influenza caused by a broad range of circulating H5 influenza strains.
› Verified 1 days ago
Oasis Counseling International Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: East Highway 20, Ainsworth, NE 69210 Phone: 402-387-1130 Fax: 402-387-1130 | |
Heartland Counseling Services, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 938 E Zero St, Ainsworth, NE 69210 Phone: 402-336-2800 |